Protolabs Reports Financial Results for the Fourth Quarter and Full Year 2022
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/20/2026
- Wall Street indexes fall, with Iran and earnings season in focus
- Oil settles 1% higher as hopes of renewed US-Iran negotiations offset Houthi threat
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
- Why Moonshot AI's Kimi K3 is actually bullish for memory stocks
- AMC Entertainment soars on record quarterly results
- U.S. to impose 50% tariff on most Canadian goods, including USMCA
- NVIDIA reports 9.3% passive stake in Nebius
- Wall Street indexes fall, with Iran and earnings season in focus
- Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
Benchmark Upgrades Proto Labs (PRLB) to Buy, '4Q22 Earnings, Forward Guidance Both Positive'
February 13, 2023 6:21 AM ESTBenchmark analyst Robert Wasserman upgraded Proto Labs (NYSE: PRLB) from Hold to Buy with a price target of $45.00.
THe analyst comments "Proto Labs reported better-than-expected financial results for their 4Q22, including revenues of $115.6 million, down 6.5% year-over-year, and nonGAAP earnings of $0.26 per share. Our estimates... More
